Publication:

Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity

Date

Date

Date
2023
Journal Article
Published version

Citations

Citation copied

Pfefferlé, M., Dubach, I. L., Buzzi, R. M., Dürst, E., Schulthess-Lutz, N., Baselgia, L., Hansen, K., Imhof, L., Koernig, S., Le Roy, D., Roger, T., Humar, R., Schaer, D. J., & Vallelian, F. (2023). Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity. Journal for ImmunoTherapy of Cancer, 11, e005718. https://doi.org/10.1136/jitc-2022-005718

Abstract

Abstract

Abstract

BackgroundAgonistic anti-CD40 monoclonal antibodies (mAbs) have emerged as promising immunotherapeutic compounds with impressive antitumor effects in mouse models. However, preclinical and clinical studies faced dose-limiting toxicities mediated by necroinflammatory liver disease. An effective prophylactic treatment for liver immune-related adverse events that does not suppress specific antitumor immunity remains to be found.MethodsWe used different mouse models and time-resolved single-cell RNA-sequencing to characterize the pathogen

Metrics

Downloads

5 since deposited on 2023-06-09
Acq. date: 2025-11-13

Views

1 since deposited on 2023-06-09
Acq. date: 2025-11-13

Additional indexing

Creators (Authors)

  • Pfefferlé, Marc
    affiliation.icon.alt
  • Dubach, Irina L
    affiliation.icon.alt
  • Dürst, Elena
    affiliation.icon.alt
  • Schulthess-Lutz, Nadja
    affiliation.icon.alt
  • Baselgia, Livio
    affiliation.icon.alt
  • Hansen, Kerstin
    affiliation.icon.alt
  • Imhof, Larissa
    affiliation.icon.alt
  • Koernig, Sandra
    affiliation.icon.alt
  • Le Roy, Didier
    affiliation.icon.alt
  • Roger, Thierry
    affiliation.icon.alt
  • Humar, Rok
    affiliation.icon.alt
  • Schaer, Dominik J
    affiliation.icon.alt
  • Vallelian, Florence
    affiliation.icon.alt

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
11

Number

Number

Number
1

Page range/Item number

Page range/Item number

Page range/Item number
e005718

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Keywords

Cancer Research, Pharmacology, Oncology, Molecular Medicine, Immunology, Immunology and Allergy

Language

Language

Language
English

Publication date

Publication date

Publication date
2023-01

Date available

Date available

Date available
2023-06-09

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
2051-1426

OA Status

OA Status

OA Status
Gold

Free Access at

Free Access at

Free Access at
DOI

PubMed ID

PubMed ID

PubMed ID

Other Identification Number

Other Identification Number

Other Identification Number
PMC9809320

Metrics

Downloads

5 since deposited on 2023-06-09
Acq. date: 2025-11-13

Views

1 since deposited on 2023-06-09
Acq. date: 2025-11-13

Citations

Citation copied

Pfefferlé, M., Dubach, I. L., Buzzi, R. M., Dürst, E., Schulthess-Lutz, N., Baselgia, L., Hansen, K., Imhof, L., Koernig, S., Le Roy, D., Roger, T., Humar, R., Schaer, D. J., & Vallelian, F. (2023). Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity. Journal for ImmunoTherapy of Cancer, 11, e005718. https://doi.org/10.1136/jitc-2022-005718

Gold Open Access
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image